BRUKX
Price
$16.11
Change
+$0.14 (+0.88%)
Updated
Jun 26 closing price
Net Assets
299.19M
VIVIX
Price
$68.70
Change
+$0.48 (+0.70%)
Updated
Jun 26 closing price
Net Assets
188.77B
Interact to see
Advertisement

BRUKX vs VIVIX

Header iconBRUKX vs VIVIX Comparison
Open Charts BRUKX vs VIVIXBanner chart's image
MFS Blended Research Value Equity R2
Price$16.11
Change+$0.14 (+0.88%)
VolumeN/A
Net Assets299.19M
Vanguard Value Index I
Price$68.70
Change+$0.48 (+0.70%)
VolumeN/A
Net Assets188.77B
BRUKX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BRUKX vs. VIVIX commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRUKX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 189B vs. BRUKX (299M). VIVIX pays higher dividends than BRUKX: VIVIX (2.29) vs BRUKX (1.18). BRUKX was incepted earlier than VIVIX: BRUKX (10 years) vs VIVIX (27 years). BRUKX (1.10) is less costly to investors than VIVIX (0.04). BRUKX is a more actively managed with annual turnover of: 55.00 vs. VIVIX (9.00). BRUKX has a lower initial minimum investment than VIVIX: BRUKX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 8.64 vs. BRUKX (0.04). VIVIX return over 5 years is better than : 81.02 vs. BRUKX (52.25).
BRUKXVIVIXBRUKX / VIVIX
Total Expense Ratio0.990.042,475%
Annual Report Gross Expense Ratio1.100.042,750%
Fund Existence10 years27 years-
Gain YTD5.2043.346156%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets299M189B0%
Annual Yield % from dividends1.182.2952%
Returns for 1 year0.048.641%
Returns for 3 years18.0730.7159%
Returns for 5 years52.2581.0264%
Returns for 10 yearsN/A110.50-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ENHCX10.410.07
+0.68%
Cullen Enhanced Equity Income C
DISRX23.87N/A
N/A
BNY Mellon International Stock Fund I
IGEAX81.10N/A
N/A
VY® T. Rowe Price Growth Equity A
NFJEX10.26N/A
N/A
Virtus NFJ Dividend Value Inst
EAMAX17.92N/A
N/A
Lord Abbett Emerging Markets Equity A